← Eichor
Study identifier: NCT07265570 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Study Evaluating ISM5411 Administered Orally to Subjects With Active Ulcerative Colitis (BETHESDA)

Condition: Ulcerative Colitis  ·  Sponsor: InSilico Medicine Hong Kong Limited

PhasePhase 2
Planned participants80
Who can joinAll sexes, 18 Years to 75 Years
Healthy volunteersNo

About this study

This is a multicenter, randomized, double-blind, placebo-controlled study to evaluate the safety, tolerability, pharmacokinetics and clinical efficacy of ISM5411 in adult patients with active ulcerative colitis.

This description comes directly from the study's public registry record.

Talk to the study team

Yang Deng  ·  +86 021-50831718  ·  Insilico-Clinicaltrial@insilico.ai

Always discuss trial participation with your own doctor first.

Locations (28)

Beijing Friendship Hospital, Capital Medical UniversityBeijing, Beijing Municipality, ChinaRecruiting
The First Affiliated Hospital of Chongqing Medical UniversityChongqing, Chongqing Municipality, ChinaRecruiting
Guangzhou First People's HospitalGuangzhou, Guangdong, ChinaRecruiting
The First Affiliated Hospital,Sun Yat-sen UniversityGuangzhou, Guangdong, ChinaRecruiting
Huizhou First HospitalHuizhou, Guangdong, ChinaRecruiting
The People's Hospital of Guangxi Zhuang Autonomous RegionNanning, Guangxi, ChinaRecruiting
The Second Hospital of HeBei Medical UniversityShijiazhuang, Hebei, ChinaRecruiting
The First Affiliated Hospital of Henan University of Science & TechnologyLuoyang, Henan, ChinaRecruiting
The First Affiliated Hospital of Xinxiang Medical UniversityXinxiang, Henan, ChinaRecruiting
Renmin Hospital of Wuhan UniversityWuhan, Hubei, ChinaRecruiting
The Third Xiangya Hospital of Central South UniversityChangsha, Hunan, ChinaRecruiting
The First Affiliated Hospital of University of South ChinaHengyang, Hunan, ChinaRecruiting

+ 16 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07265570